A novel zinc finger gene, ZNF465, is inappropriately expressed in presentation acute myeloid leukaemia cells
AuthorsCollin, Joseph F.
Wells, James W.
Duriez, Patrick J.
Banham, Alison H.
Mufti, Ghulam J.
AffiliationKing's College London
University of Oxford
Southampton University Hospitals Trust
University of Bedfordshire
MetadataShow full item record
AbstractTo increase our knowledge of leukaemia-associated antigens, especially in acute myeloid leukaemia (AML) M4, we prepared a phage display cDNA library using mRNA from the bone marrow cells of a patient with AML M4 at diagnosis. We immunoscreened 10(6) pfu with autologous sera and identified an antigen which we named GKT-AML8. The cDNA showed more than 99% similarity to a sequence on 2q21.2 and 95% sequence similarity to a sequence on 19q13.3. These genes were named ZNF465 and ZNF466, respectively, following HUGO Gene Nomenclature Committee (HGNC) guidelines. Expressed sequence tag data suggests that both genes are transcriptionally active. ZNF465 and ZNF466 encode a 5' krüppel associated box domain typical of negative regulators of gene transcription. We have confirmed the translational start site in the +1 frame in a near-Kozak sequence that produces a 102 amino acid polypeptide from ZNF465. The high level of sequence similarity between ZNF465 and ZNF466 makes their transcripts almost indistinguishable by real-time polymerase chain reaction (RT-PCR). However, GKT-AML8 showed most sequence similarity to ZNF465 and no transcript matching the 3' ZNF466 sequence could be detected in patient samples or healthy volunteers. ZNF465/466 expression was detectable in 12/13 AML and 10/14 chronic myeloid leukaemia patients' samples but not in normal donor peripheral blood (0/8) or 0/3 bone marrow samples which had been separated into CD34(+) and CD34(-) samples. The altered expression of ZNF465/466 in patients' samples and its absence in healthy donor haematopoietic samples indicate that ZNF465 is overexpressed in early myeloid disease and as such may represent a promising target for immunotherapy.
CitationCollin, J.F., Wells, J., Czepulkowski, B., Lyne, L., Duriez, P., Banham, A.H., Mufti, G.J. & Guinn, B.A. (2015) 'A novel zinc finger gene, ZNF465, is inappropriately expressed in presentation acute myeloid leukaemia cells.' Genes, Chromosomes & Cancer, Vol. 54, pp. 288-302.
JournalGenes, Chromosomes & Cancer
- Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
- Authors: Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E
- Issue date: 1995 Jun
- Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
- Authors: Guinn BA, Bland EA, Lodi U, Liggins AP, Tobal K, Petters S, Wells JW, Banham AH, Mufti GJ
- Issue date: 2005 Oct 7
- SOX12: a novel potential target for acute myeloid leukaemia.
- Authors: Wan H, Cai J, Chen F, Zhu J, Zhong J, Zhong H
- Issue date: 2017 Feb
- Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
- Authors: Atanackovic D, Luetkens T, Kloth B, Fuchs G, Cao Y, Hildebrandt Y, Meyer S, Bartels K, Reinhard H, Lajmi N, Hegewisch-Becker S, Schilling G, Platzbecker U, Kobbe G, Schroeder T, Bokemeyer C, Kröger N
- Issue date: 2011 Nov
- Simultaneous expression of different immunogenic antigens in acute myeloid leukemia.
- Authors: Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Huebsch S, Maurer U, Bergmann L, Schmitt M
- Issue date: 2000 Dec